---
title: "GRIN3A"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: GRIN3A"
tags: ['GRIN3A', 'NMDAreceptor', 'neurodevelopmentaldisorders', 'epilepsy', 'missensemutation', 'memantine', 'synapticplasticity', 'neurologicaldisorders']
---

# Gene: GRIN3A
## Information

- **Pathology:** NMDA receptors play important roles in synaptic plasticity and are implicated in various neurological and psychiatric disorders. In particular, GRIN3A mutations have been associated with epilepsy and neurodevelopmental disorders.

- **Function:** The GRIN3A gene encodes for the Glutamate Ionotropic Receptor NMDA Type Subunit 3A protein that is a subunit of the N-methyl-D-aspartate (NMDA) receptor, which is involved in excitatory synaptic transmission and synaptic plasticity.

- **External IDs:**

  - Gene ID: [116443]([Click](https://www.ncbi.nlm.nih.gov/gene/116443))
  - Genomic location: [Chr9:79,663,214-80,114,547]([Click](https://www.ncbi.nlm.nih.gov/gene/116443)) (GRCh38.p13)
  - Aliases: GLUN3A, GRINL1A 
  
- **External Sites:**

  - HGNC: [HGNC:19033]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:19033))
  - NCBI Entrez: [116443]([Click](https://www.ncbi.nlm.nih.gov/gene/116443))
  - Ensembl: [ENSG00000185003]([Click](https://grch38.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185003))
  - OMIM: [605645]([Click](https://www.omim.org/entry/605645))
  - UniProtKB/Swiss-Prot: [Q8TCU5]([Click](https://www.uniprot.org/uniprot/Q8TCU5))

- **AA Mutation List:**

  | AA Mutation | Mutation Type | dbSNP ID |
  |-------------|---------------|----------|
  | E399D | Missense | [rs369262731]([Click](https://www.ncbi.nlm.nih.gov/snp/rs369262731/)) |
  | T676I | Missense | [rs587777047]([Click](https://www.ncbi.nlm.nih.gov/snp/rs587777047/)) |

- **Somatic SNVs/InDels:**

  There are no somatic SNVs/InDels associated with GRIN3A in dbSNP.

- **Related Disease:**

  - Epileptic encephalopathy, early infantile, 44 (OMIM: 617132)

- **Treatment and Prognosis:**

  There is no cure for epilepsy, but medications and other treatments can help manage the condition.

- **Drug Response:**

  There are no drugs currently approved specifically for GRIN3A related disorders. However, NMDA receptor antagonists such as memantine have been used for treatment of epilepsy.

## References

- Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., ... & Klopocki, E. (2010). Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nature genetics, 42(11), 1021-1026.

- Lin, Y. W., Min, M. Y., & Chiu, T. H. (2019). NMDA receptor regulation of synaptic signaling in depression. BioMed Research International, 2019.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**